Delpor-preview

Delpor

Private

Brisbane, CaliforniaHealthcare & Life Scienceshttps://delpor.com/

Last Round

Grant

Nov 16, 2021

Total Funding Raised

$10.26M

Company Overview

Delpor is a clinical-stage biopharmaceutical company that develops once-yearly therapies for chronic diseases using innovative subcutaneous implant technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

implantable drug deliverydrug implantlong-acting implantschizophrenia treatmentPROZORmedication adherenceCNS therapiesopioid use disorder treatmentdrug delivery platformsustained release deliveryzero-order release kineticsdrug-device combinationsubcutaneous implant505(b)(2) pathwayclinical-stage biopharmapharma licensingNANOPOR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delpor Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Delpor Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 16, 2021
Grant	Oct 14, 2019
Grant	Jun 14, 2017
Grant	Feb 9, 2017
Series A	Mar 28, 2016
Grant	Jun 20, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Tassos Nicolaou

President & CEO

Executive Team

Delpor Investors

Notable investors and investment history

Investor	Rounds
National Institute of Mental Health	Grant
Fondazione Hub Innovazione Trentino	VC Round
NIH RADx	Grant
Cloudstone Capital	VC Round
Kairos Ventures	Series A
National Institute of Diabetes and Digestive and Kidney Diseases	Grant
Ulu Ventures	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 11, 2025
Monthly visitors increased 54% MoM, reaching 1.7K.
Jun 1, 2025
Monthly visitors grew 69% MoM, reaching 1.4K.

View all signals

Delpor Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Delpor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delpor's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane, California

Employee Range5

Year Founded2009

Last FundingNov 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.